Jim Wassil, CHIEF OPERATING OFFICER at Vaxcyte, Inc. (PCVX), sold 16,000 shares at $94.06 ($1.5M) on 2024-12-02, disclosed to the SEC on 2024-12-03.
Scheduled sale ($1.5M) by CHIEF OPERATING OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $92.07 | 5,772 | $531K | 35.9% |
| 2 | $92.07 | 5,772 | $531K | 35.9% |
| 3 | $93.06 | 1,101 | $102K | 6.9% |
| 4 | $93.06 | 1,101 | $102K | 6.9% |
| 5 | $94.06 | 1,127 | $106K | 7.2% |
| 6 | $94.06 | 1,127 |
| $106K |
| 7.2% |
| Total | $92.49 avg | 16,000 | $1.5M | 100% |
| Filing → |
| PCVX | SELL | 2026-09-02 | $212K | — | Filing → |
| PCVX | SELL | 2026-08-05 | $121K | — | Filing → |
| PCVX | SELL | 2026-07-06 | $127K | — | Filing → |